We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Clinical Studies Need Therapeutic Intent for Medicare Reimbursement
Clinical Studies Need Therapeutic Intent for Medicare Reimbursement
February 27, 2009
Drugmakers that want the cost of their products reimbursed by the Centers for Medicare & Medicaid Services (CMS) for Phase I or II clinical trials must make sure the studies clearly indicate therapeutic intent.